Pharmaste Daily: October 1, 2026

Go to the current selection →

DAILY SELECTION · October 1, 2026

Question focus: Pharmacy math. Drug cards rotate across medication classes.

QUESTION OF THE DAY

Make a choice. Understand the why.

Log in with a confirmed account to save your submitted response. Multiple-response questions require the complete correct set; this is Pharmaste practice feedback, not a claim about NABP scoring.

0 of 1 answered. Your latest responses are used for your recap; you can revisit any set.

Loading your question…

Continue with pharmacy math →

DRUG OF THE DAY

insulin glargine

Long-acting basal insulin

Before opening the card, recall one use, one safety check and one counseling point.

Reveal the drug learning card

Names and formulations

  • Lantus: U-100 insulin glargine vial and SoloStar pen
  • Toujeo: U-300 insulin glargine SoloStar and Max SoloStar pens

Lantus U-100 and Toujeo U-300 concentrations, devices, and product names must be verified every time; conversion may require dose adjustment and closer glucose monitoring.

Common use

Improves glycemic control in patients with diabetes mellitus; age indications differ by product.

Mechanism of action

Provides basal insulin-receptor activity that promotes peripheral glucose uptake and inhibits hepatic glucose production.

Important adverse effects and monitoring

  • Hypoglycemia is the most common serious risk; monitor glucose and individualize targets and dose changes.
  • Insulin can cause hypokalemia; monitor potassium in patients at risk.
  • Prevent medication errors by checking label, concentration, device, and dose before every injection.

Patient counseling

  • Never share a pen, even if the needle is changed; use a new needle and rotate injection sites.
  • Do not dilute or mix insulin glargine with another insulin and follow the product-specific storage and missed-dose plan.

Interaction to recognize

With: beta blockers

Why it matters: Can blunt adrenergic warning symptoms of hypoglycemia, although sweating may persist.

Practical response: Use glucose monitoring and teach nonadrenergic warning signs rather than relying only on palpitations or tremor.

Check the original sources

Selected learning points; verify current labeling for the complete prescribing information.

Featured from our existing free, reviewed collections. Revisit a concept as it returns in the rotation. Featuring a resource today does not change its original source-check date.

Browse past selections →